Intellia Therapeutics Inc
NASDAQ:NTLA
Wall Street
Price Targets
NTLA Price Targets Summary
Intellia Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
NTLA
is 72.38 USD
with a low forecast of 24.24 USD and a high forecast of 151.2 USD.
NTLA Last Price Targets
Intellia Therapeutics Inc
The latest public price target was made on Feb 1, 2023 by
Unknown Analyst
from
Cantor Fitzgerald
,
who expects
NTLA
stock to
rise by 188%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Unknown Analyst
Cantor Fitzgerald
|
67
USD
Upside 188% |
1 year ago
Feb 1, 2023
|
Cantor Fitzgerald Initiates Coverage On Intellia Therapeutics with Overweight Rating, Announces Price Target of $67
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NTLA's stock price target?
Price Target
72.38
USD
According to Wall Street analysts, the average 1-year price target for
NTLA
is 72.38 USD
with a low forecast of 24.24 USD and a high forecast of 151.2 USD.
What is Intellia Therapeutics Inc's Revenue forecast?
Projected CAGR
46%
For the last 8 years the
compound annual growth rate for
Intellia Therapeutics Inc's revenue is
25%.
The projected
CAGR
for the next 3 years is
46%.
You don't have any saved screeners yet
